Stay updated on Durvalumab Consolidation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Consolidation in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedAdded Record History and Study Record Versions with version-by-version details and a compare option, plus related UI elements (Results Posted, Researcher View, Study Details, Download, Save) to improve traceability of the trial record.SummaryDifference39%

- Check24 days agoChange DetectedRevision: v3.4.3 added; several history-related sections appear removed or hidden, with updated UI for versioning.SummaryDifference14%

- Check31 days agoChange DetectedA new Study Status entry was added on 2026-02-10 and an earlier entry was removed on 2025-11-10 in the record history.SummaryDifference0.2%

- Check38 days agoChange DetectedThe new version adds multiple study locations (and their contacts) and removes several previously listed locations. This updates the geographic coverage and contact points shown in the study record.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page history shows a new revision label (v3.4.2) replacing v3.4.1, a minor site update that does not affect study data or user-facing content; to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed; no substantive content changes to the study record are visible.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Consolidation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.